Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion type Assertion NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_head.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion description "[reduced transforming growth factor-beta type II receptor expression may play a critical role in determining the malignant phenotype of human adrenocortical carcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_provenance.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion evidence source_evidence_literature NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_provenance.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion SIO_000772 16673206 NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_provenance.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion wasDerivedFrom lhgdn-20090331 NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_provenance.
- NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_assertion wasGeneratedBy ECO_0000203 NP213233.RA4WFEMK9vab-2OG5WACV9SfvluBThtYQfh9nNh8Jd9sk130_provenance.